Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. | Takeda Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 1987 | Founding Date 1781 | Founding Date 1921 | Founding Date 1978 | Founding Date 2012 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more | Locations Shanghai, CN HQ | |
Employees | Employees 43 | Employees 49,281 | Employees 1,6451% decrease | Employees 16,315 | Employees 2,5321% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.3t (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ₹142b (FY, 2024) | Revenue (est.) ¥1.5b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods ¥698.7b (FY, 2024) | Cost of goods N/A | Cost of goods ₹50.9b (FY, 2024) | Cost of goods ¥541m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit ¥3.6t (FY, 2024) | Gross profit N/A | Gross profit ₹102b (FY, 2024) | Gross profit ¥941.9m (FY, 2023) |
Net income | Net income ($114.8m) (FY, 2021) | Net income ¥144.2b (FY, 2024) | Net income N/A | Net income ₹13b (FY, 2024) | Net income (¥2.5b) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 171.7m | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |